Hyperthyroidism treatment like radioactive iodine or surgery was associated with a decreased risk for death, according to research being presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago.
Jun 18, 2023
0
4
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
A combination of pretherapy imaging and dosimetry can help ensure that patients with refractory differentiated thyroid cancer obtain the maximum benefit from radioactive iodine treatments following redifferentiation therapy. ...
Jun 22, 2023
0
4
Iodine deficiency (ID) is the world's leading cause of preventable brain damage. The EU-funded project EUthyroid has set up the first joint European database that can provide information on iodine status and thyroid disease ...
Oct 10, 2018
0
2
In a summary of a recent guideline from the National Institute for Health and Care Excellence (NICE), published online Jan. 29 in The BMJ, recommendations are presented for the assessment and management of thyroid disease.
Mar 4, 2020
0
0
(HealthDay) -- Most people in the United States are getting adequate nutrition, but some groups experience lower levels of vital nutrients than that which is recommended for good health, according to the Second National Report ...
Apr 3, 2012
0
0
For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of nearly 12,000 people in Belarus who were exposed when ...
Oct 28, 2014
0
1
Nearly a million Americans live with thyroid cancer and doctors will diagnose more than 50,000 new cases this year. Fortunately, the survival rate for this kind of cancer is one of the best. Five years after diagnosis, more ...
Jul 10, 2019
0
0
According to an accepted manuscript published in the American Journal of Roentgenology, ringlike peripheral high iodine concentration maps from dual-energy CT (DECT) can help guide management in patients with known lung cancer ...
Jan 11, 2023
0
2
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher ...
Jun 2, 2013
0
0
